Satisfaction With Pediatric Intravenous Catheter Placement in the Emergency Department

Terminated

• Conditions: Intravenous Placement Procedure
• Interventions: Behavioral: Zingo TM (lidocaine hydrochloride monohydrate) powder intradermal injection system

• Registration Number: NCT00766181
• Lead Sponsor: Anesiva, Inc.

Brief Summary

The purpose of this study is to determine the satisfaction among parents and nurses of pediatric patients with IV catheter placement in the Emergency Department.

Detailed Description

The objectives of this study are to evaluate whether the proportion of parents satisfied with their child's IV placement procedure is higher after the introduction of Zingo compared to standard of care and to evaluate changes in nursing staff satisfaction with performing IV placement procedures after using Zingo prior to IV placement compared to standard of care.

Study Timeline

• Study Start: 2008-10
• Study First Submitted: 2008-10-01
• Study First Submitted QC: 2008-10-02
• Study First Posted: 2008-10-03
• Status Verified: 2008-11
• Primary Completion: 2009-02
• Study Completion: 2009-04
• Last Update Submitted: 2010-05-24
• Last Update Posted: 2010-05-25

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• PHASE A: Parent of a pediatric patient from the age of 3 to 18 years of age who requires a peripheral IV placement in the Emergency Department
• Parent must be able to read and understand English and provide written informed consent
• Parent must be present during the IV placement
• PHASE B: Parent did not participate in Phase A
• Nurse has completed Zingo TM in-service training prior to participation
• Zingo is used prior to performing the IV placement procedure

Exclusion Criteria

• Parent of patient with a serious unstable medical or psychological condition that would compromise participation in the study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
2: Lifestyle	Zingo TM (lidocaine hydrochloride monohydrate) powder intradermal injection system	Observational

Primary Outcome Measures

Name	Time	Method
Parent's satisfaction with IV placement procedure	18 weeks

Secondary Outcome Measures

Name	Time	Method
Nurse'e satisfaction with performing IV placement	18 weeks